Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: cancer vaccine

cancer vaccine stories: 7 news summaries

(Newser) - After decades of false starts, doctors are tapping the immune system to help stave off cancer, USA Today reports. Using proteins from patients' tumors, American researchers have created a vaccine that can put off lymphoma relapses by 14 months. In one study, a cocktail of the vaccine and two other... More »

MORE ABOUT:
cancer • cancer vaccine • lymphoma • study • immune system • tumors

Brain Cancer Vaccine Doubles Survival Time

Kennedy could be
a candidate for breakthrough therapy

Jun 3, 08 11:41 AM CDT
(Newser) - A new vaccine more than doubles the expected survival time of patients with the most common form of brain cancer, Reuters reports. Although the test group was small, patients lived an average of 33 months—"almost unheard of" compared to the average of 14 months, says one doctor. The... More »

MORE ABOUT:
cancer vaccine • Ted Kennedy • survival rates • tumor • brain cancer • glioma

Breast Cancer Vaccine Passes Safety Test

18 patients treated without harm, some benefit seen in slowing disease

Aug 19, 07 12:05 PM CDT
(Newser) - A breast cancer vaccine is one step closer to FDA approval after a study found it produced no harmful effects in 18 women treated, and showed some signs of slowing tumors, Reuters reports. Neuvenge is meant to treat people who already have cancer by triggering the immune system to fight... More »

MORE ABOUT:
cancer • breast cancer • cancer vaccine • vaccine • cancer research • cancer treatment • Neuvenge

Tobacco Used in Cancer Vaccine

Scientists who developed HPV vaccine work on a cheaper version—±±

Jul 30, 07 11:21 AM CDT
(Newser) - The same researchers who developed Gardasil—the vaccine that can prevent cervical cancer—have genetically engineered tobacco plants to produce a cheaper version of the vaccine. The new drug, designed for distribution in India and other poor countries, would cost $3 for three doses, as opposed to $360 for Gardasil,... More »

MORE ABOUT:
cancer • cancer vaccine • HPV • cervical cancer • Gardasil • tobacco • vaccine

Conservatives Wield FDA Data on HPV Vaccine

Cite health risks in opposing vaccination
of teenage girls

May 24, 07 3:31 PM CDT
(Newser) - A group of religious conservatives has marshalled unreleased FDA data as a weapon in the battle against  Gardasil, the new cervical cancer vaccine. The data indicates health problems in women taking the vaccine, but  drugmaker Merck and the FDA both insist that the negative effects are probably unrelated to the... More »

MORE ABOUT:
cancer • FDA • health • women's health • cancer vaccine • Merck • HPV • cervical cancer • Gardasil • women • vaccination • vaccine • teen health

Vaccine May
Not Prevent
Cervical Cancer

Mandated for all girls
in some states, HPV vaccine fails to deliver 

Apr 16, 07 8:43 AM CDT
(Newser) - Pharma behemoth Merck is defending what it touted as a miracle cervical-cancer vaccine against charges of ineffectiveness. Merck lobbied states to mandate Gardasil for young girls—Texas and Virginia did—and got a glowing endorsement from the CDC. But new studies show that it works only to prevent sexually-transmitted HPV,... More »

MORE ABOUT:
cancer • health • cancer vaccine • Merck • HPV • cervical cancer • Gardasil • Centers for Disease Control and Prevention • pharmaceutical companies • pharma • vaccine • STD

FDA Panel Passes First Cancer Vaccine

Prostate treatment recruits immune system
to fight tumors

Mar 30, 07 11:20 AM CDT
(Newser) - A cancer drug that's the first to harness the body's immune system to destroy tumors got a thumbs-up from  the FDA's advisory panel, the New York Times reports. If approved, Provenge, a prostate cancer treatment, would be the first of the "cancer vaccines"—experimental therapies that commandeer a... More »

MORE ABOUT:
cancer • FDA • health • prostate cancer • cancer vaccine • vaccine • Provenge

7 Stories


from our news partners